Navigation Links
Hard To Treat Diseases (HTDS) Recapitalization
Date:1/9/2009

BELGRADE, Serbia, Jan. 9 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS) www.htdsmedical.com the company having recently completed a merger with Slavica Bio Chem (Formerly ReNuYu Biochem) intends to recapitalize to 5 billion shares to pay for the Slavica merger and the pending China Bio Chem merger. Consideration for Slavica is 300 million non-dilatable restricted shares to be distributed amongst all doctors involved in Belgrade Serbia research. Key medical consultants and X ReNuYu management will receive stock options at a .03c strike price for up to 9% of the company common stock.

At present the company stock formulation details are as follows: Number of Common Shares Authorized: 1,200,000,000. Number of Common Shares Outstanding 862,581,959. Number of Restricted Shares: 480,091,291 Number of Preferred Shares Authorized: 25,000,000. Number of Preferred Shares Issued: None. The company intends to issue 10,000 convertible preferred shares to secure debt financing of about 1.5 million dollars.

The company's primary focus involves the enhancement and modification of existing approved drugs such as "Virazole" for the purpose of chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV. Other interests include an on line cosmetics company.

The company will provide further details as they become available.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: Certain information contained in this release contains forward-looking statements that involve risk and uncertainties, including but not limited to, those relating to development and expansion activities, domestic and global conditions, and market competition.

CONTACT: For scientific dialogue and any medical inquiry only please contact Andrea Rubio Zecevic via e-mail at

SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Study Finds More Effective Treatment for Pneumonia Following Influenza
2. Study finds more effective treatment for pneumonia following influenza
3. Identification of genetic markers for ulcerative colitis could lead to treatment
4. Physicians Express Continued Need for Safe and Effective Nonstimulant Therapies in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder
5. Hard To Treat Diseases (HTDS) Set To Acquire Cosmetics Company
6. Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment
7. Kawasaki Disease Treated with Plasma-Derived Therapy
8. Unnecessary Spinal Surgery Will Waste Billions of Dollars in 2009 and Patients Will Continue to Suffer Unless the Primary Cause of Most Back Pain is Treated, Says Pain Specialist Norman Marcus, M.D.
9. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
10. First RapidArc Radiotherapy Treatment in Italy Takes Place at Leading Milan Cancer Center
11. Dr. Mitchell L. Petusevsky, M.D., F.C.C.P. Meets Growing Demand for the Treatment of Sleep and Pulmonary Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2009)...results, study says , , FRIDAY, July 3...ates scored better than their counterparts in Engl...se of differences in levels of depression and educ...re aggressive treatment for heart disease, a new s...d delayed recall of 10 common nouns, such as tree,...
(Date:7/3/2009)...e to breaking news of drugs reportedly found at th...ociety of Anesthesiologists releases the following...esiologists (ASA), which is made up of , physicia...t know the specific circumstances surrounding Mich...y maintains that Diprivan, or its generic name Pro...
(Date:7/3/2009)...ish knows what it,s like being addicted to prescri...America,s "Other" Drug Problem Prescription Medica... his story of addiction and recovery and how he go...m Center drug and alcohol rehabilitation program...m/09-0703-NarcononMI_72dpi.jpg ) , *(Photo Capti...
(Date:7/3/2009)...iddle age may triple the risk, study shows , ...-aged adults who live alone are twice as likely to...life compared to those who are married or live wit...ong those who are divorced or widowed, according t..., The study included 2,000 men and women in Fin...
Breaking Medicine News(10 mins):Health News:On Memory, Older Americans Outsmart the English 2Health News:American Society of Anesthesiologists Releases Following Statement Related to Media Inquires Regarding Michael Jackson's Death 2Health News:Narconon Graduate Successfully Recovers From Prescription Drug Abuse 2Health News:Living Alone Increases Odds of Developing Dementia 2
...ion in lessening the symptoms of fibromyalgia.Rese...roup of 120 patients diagnosed with fibromyalgia, ...well understood.// Half of the patients were initi...erobic exercise, supervised by a personal trainer....
...block the death of brain cells in mice who have Hu...n's disease (HD), which is a rare degenerative bra...hers at the University of Texas may be one step cl...eriments on mice with HD. The mice were treated w...
... research center feel, that we need to learn more...adiowaves and microwaves play an increasing role i... computers and personal digital assistants, pagers...t cellphone base stations, often unaware of their ...
...fed with more registered nurses (RN) the most high...lications, and researchers say in a study that is ...wing nursing shortage.``Will we see more of these ...dge of the registered nurses in the clinical setti...
Other Medicine News:Health News:Nurses save more lives 2
(Date:7/3/2009)...PRNewswire/ -- BioCis Pharma Ltd., a privately,he...in Turku, Finland,announced positive results fro...mulsion cream, the company,s novel topical drug fo...led study, conducted in Finland, included 13,pati...pplied the ProtoCure,emulsion cream to the affect...
(Date:7/2/2009)...Tenn., July 2 Acura Phar...aceuticals, Inc. (NYSE: KG ) announced today tha...issued a Complete Response Letter regarding the Ne..., USP and niacin, USP) Tablets CII, an immediate r...-to-severe pain. , , (Logo: http://www.new...
(Date:7/1/2009)... 1 The largest study of,... revealed several new common,single-letter varian...ed to,risk of the disease. The study, by a multin...om deCODE genetics (Nasdaq: DCGN ), analyzed the ...participants from fourteen countries.,It is publi...
(Date:6/30/2009)...RNewswire/ -- If you have been eating Garlic to ke.... While there is absolutely no scientific evidenc...y, spraying garlic has plenty of evidence to prove...ct on grassy lawns is not as strange as it seems. ...abs, Inc. is being used successfully by city parks...
Breaking Medicine Technology:BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 2Acura and King Receive FDA Complete Response Letter Regarding Acurox(R) 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc. 2Most babies with uncomplicated febrile seizures can avoid spinal tap 33196 1Most babies with uncomplicated febrile seizures can avoid spinal tap 33196 2Most babies with uncomplicated febrile seizures can avoid spinal tap 33196 3Baxter International Fourth Quarter 2008 Financial Results Conference Call 33194 1AMERIGROUP Corporation to Present at the 27th Annual J P Morgan Healthcare Conference on January 14 33192 1Halo Pharmaceutical Inc Acquires Whippany Manufacturing Facility from Abbott 33189 1Halo Pharmaceutical Inc Acquires Whippany Manufacturing Facility from Abbott 33189 2Halo Pharmaceutical Inc Acquires Whippany Manufacturing Facility from Abbott 33189 3
...07 /PRNewswire/ -- At the April AACR,Annual Meetin...scientific basis for a new drug test-platform to p...erived primary cell lines are currently the first,...l selection and,expansion, however, their gene and... thereby losing many of their primary,characterist...
...wire/ -- Bayer HealthCare,Pharmaceuticals announce... Betaseron(R) (interferon beta-1b), presented this... 59th Annual Meeting,demonstrating early efficacy...ction with treatment in patients with relapsing,fo...hese studies highlight the important clinical,bene...
Other Medicine Technology:Indivumed Study Provides Sound Scientific Basis for a Predictive,Drug Test- Platform 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4
Surgitie&trade Single Use Ligating Loops with Delivery System
Surgitie&trade Single Use Ligating Loops with Delivery System
Surgitie&trade Single Use Ligating Loops with Delivery System
ENDO STITCH&trade Triple-Stitch Single Use Loading Units for use with ENDO Stitch* 10 mm Suturing Device.
Medicine Products: